$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
Abraxane治疗转移性乳腺癌的安全性和有效性
2025-10-19 11:44:20
Check Details
Abraxane在治疗转移性乳腺癌这方面的效果显著
2025-10-19 11:44:20
Check Details
Abraxane能有效改善转移性乳腺癌患者生存期
2025-10-19 11:44:20
Check Details
Abraxane对转移性乳腺癌有着不错的疗效
2025-10-19 11:44:20
Check Details
乳腺癌重磅治疗药物:Abraxane
2025-10-19 11:44:20
Check Details
乳腺癌是什么?怎么检测出来的?用什么药治疗?
2025-10-19 11:44:20
Check Details
瑞博西尼治疗HR+/HER2乳腺癌的安全性和有效性
2025-10-19 11:44:20
Check Details
瑞博西尼在2021年纳入国家医保了吗?
2025-10-19 11:44:20
Check Details
抗癌药瑞博西尼哪里有售?价格是多少?
2025-10-19 11:44:20
Check Details
瑞博西尼治疗HR+/HER2乳腺癌患者的效果显著
2025-10-19 11:44:20
Check Details
瑞博西尼使晚期或转移性乳腺癌患者又多了一种选择
2025-10-19 11:44:20
Check Details
瑞博西尼的出现,给乳腺癌患者带来了哪些好处?
2025-10-19 11:44:20
Check Details
1
2
...
2002
2003
2004
2005
2006
2007
2008
...
4163
4164
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
How to Take Tucatinib (Tukysa): Dosing Schedule, Combination Use & Missed Dose Guidance
2
Anamorelin (ADLUMIZ): GHS-R1a Agonist for Cancer Cachexia—Mechanism, Use, and Safety Boundaries
3
Vemurafenib Mechanism and Clinical Indications: BRAF V600E Mutant Melanoma and ECD Treatment
4
Ribociclib: Mechanism of Action and Approved Uses in Breast Cancer
5
Binimetinib + Encorafenib: Dual MEK/BRAF Targeting in BRAF+ Tumors
6
Neratinib Dosing: 240mg Start, Diarrhea Prophylaxis, Hepatic Adjustment
7
Selumetinib and KRAS Mutations: Where the MEK Inhibitor Actually Fits
8
Erdafitinib in Lung Squamous Cell Carcinoma: Indication Boundaries and FGFR Interpretation
9
Daraxonrasib (Rasonque): Chemical Identity and RAS Tri-Complex Mechanism
10
Tamoxifen and Feeling Older: Managing Hot Flashes, Fatigue, and Skin Changes
11
FDA Approves Pembrolizumab for TMB-H Solid Tumors: Threshold ≥13 mut/Mb, KEYNOTE-158 Data
12
Capmatinib for METex14 NSCLC: Test First, Monitor Toxicity